Gallo Investigation: A `Messy Business' Raises Many Issues

Gallo Investigation: A `Messy Business' Raises Many Issues Author: SCOTT HULER As the probe into alleged misconduct by the National Cancer Institute lab of Robert Gallo in its search for the AIDS virus deepens, the scope of the investigation broadens as well. Recently joining the National Institutes of Health's Office of Scientific Integrity (OSI) in its long-running investigation of Gallo are the General Accounting Office, the Department of Health and Human Services, and the Ho

Written byScott Huler
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

As the probe into alleged misconduct by the National Cancer Institute lab of Robert Gallo in its search for the AIDS virus deepens, the scope of the investigation broadens as well.

Recently joining the National Institutes of Health's Office of Scientific Integrity (OSI) in its long-running investigation of Gallo are the General Accounting Office, the Department of Health and Human Services, and the House Subcommittee on Oversight and Investigations.

And now, according to recent reports, NIH is investigating its own investigation, asking the FBI to determine how early results of the OSI report leaked to the press. As a result of the affair, the scientific community confronts professional issues whose implications extend beyond the charges leveled at Gallo's lab.

The various investigations are considering allegations originally raised in a 1989 special report by the Chicago Tribune. The newspaper charged that Gallo's lab failed to isolate its own human immunodeficiency virus, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies